A difference of opinion between veteran investors sends a signal to the rest of us about the upheaval that could be caused by ...

Wall Street is overly focused on GLP-1 drugs even as this medical device maker continues to thrive. Drugmakers Novo Nordisk and Eli Lilly are battling it out in the GLP-1 weight loss market. The pill ...

Combinging medications like Ozempic and Wegovy. But for the best results, they should be combined with exercise and healthy eating habits.

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...

Online telehealth company Hims & Hers Health , seeking growth drivers as its original sexual-health franchises matured, may have overstepped with a risky launch of weight-loss pills that drew swift ...

Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs.

For years, weight loss advice has been all about diet trends, fitness challenges, and social-media hacks. Yet physicians who specialize in metabolic health will tell you this: lasting weight loss ...

Demand for GLP-1 drugs continues to climb, boosted by a major price drop and the FDA’s approval of an oral Wegovy pill that ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of ...

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...

Novo Nordisk (NVO) stock will produce Wegovy pills in Ireland after attracting 240,000 users in five weeks as CEO battles Eli ...